Status:
COMPLETED
Perioperative Duloxetine for Pain Management After Laparoscopic Hysterectomy
Lead Sponsor:
Acibadem University
Conditions:
Laparoscopic Hysterectomy
Postoperative Recovery
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of the investigators of the study is to evaluate the effect of peri-operative duloxetine on post-operative recovery in patients undergoing laparoscopic hysterectomy.
Detailed Description
Patients with benign gynecologic conditions (fibroids, pelvic pain, uterine prolapse) who are planned to undergo laparoscopic hysterectomy will be enrolled in the study. After randomization, the study...
Eligibility Criteria
Inclusion
- Patients with benign gynecologic conditions (fibroids, pelvic pain, uterine prolapse) who are planned to undergo laparoscopic hysterectomy will be enrolled in the study
Exclusion
- Patients with chronic non-gynecologic conditions (liver or pulmonary disease, diabetes), using psychiatric drugs (anti-depressants, neuroleptics, lithium) in the last 1 year, those with duloxetine allergy, and patients using opioids for gynecologic or non-gynecologic conditions will be excluded from the study.
Key Trial Info
Start Date :
December 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03350334
Start Date
December 4 2017
End Date
March 15 2018
Last Update
May 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem Maslak Hospital
Sarıyer, Istanbul, Turkey (Türkiye), 34457